The FDA said it had rejected a cell therapy intended for patients with Duchenne muscular dystrophy developed by Capricor ...
A graduate student who is a scientific researcher at Princeton was detained by ICE while traveling home after presenting ...
Medicare pilot will test ‘food is medicine’ and other lifestyle programs to counter chronic diseases
Medicare does not cover many of the lifestyle interventions that could keep people from getting sick in the first place.
Sanofi weighs an Insmed takeover, the FDA slams J&J over misleading bladder cancer drug claims, and more pharma news: ...
Tax filings show the MAHA Institute spent more than $1 million in 2025, ending its first year with just $171,000 as events ...
STAT reporters preview JPM 2027, sharing the trends, companies, rumors, and stories to watch at the J.P. Morgan Healthcare ...
Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The acting director of the National Institute of Allergy and ...
A monoclonal antibody holds promise in preventing malaria, but researchers found it interfered with a new vaccine when used ...
The National Academies urged the scientific community to respond more aggressively to claims of errors or manipulated data in ...
Did the biotech company Erasca find a more potent, better-tolerated pan-RAS cancer drug than Revolution Medicines?
Infectious disease physician and STAT “ID Consult” columnist Krutika Kuppalli offers Congress a must-do list on measles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results